Pediatrics

Silicone nipple shields that protect the nipples and facilitate breastfeeding Device that helps reduce breastfeeding discomfort

This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. It is used to treat a wide variety of bacterial infections (e.g., middle ear, urinary tract, respiratory, and intestinal infections). It is also used to prevent and treat certain types of pneumonia (pneumocystis). It has a moderately broad antibacterial spectrum, acting on gram-positive cocci and aerobic gram-negative cocci and bacilli, especially Enterobacteriaceae.

Tempra® 80 mg Grape Flavor Chewable Tablets is a children's analgesic with paracetamol, an aid in the relief of fever and pain in children between 2 and 5 years of age.

Tempra® Pediatric Drops 30 ml grape flavor, is an analgesic with auxiliary paracetamol for the relief of fever and pain in newborns and children up to 36 months

It is indicated for the treatment of influenza virus group A, including subtypes H3N2, H2N2 and H1N1, as it has specific antiviral, analgesic, antipyretic, decongestant and antihistamine action.

OINTMENT FOR THE TREATMENT AND PREVENTION OF DIAPER RASH THAT NEUTRALIZES THE LESION, REGENERATES THE SKIN (VITAMINS A, D, AND ZINC OXIDE), AND CREATES A BARRIER THAT SEALS THE SKIN'S MOISTURE (ALLANTOIN). "If you notice any adverse reaction, discontinue use, and if it persists, consult your doctor. For external use only."

AMIKACIN-AMSA INJECTION 500 Amikacin injection belongs to a class of medications called aminoglycoside antibiotics. It works by eliminating bacteria. Antibiotics such as amikacin injection do not work against colds, influenza, or any other viral infection. C/1 Therapeutic Indications Amikacin Short-term treatment of serious infections caused by gram-sensitive microorganisms: Pseudomonas, E. coli, Proteus (indole-positive and indole-negative), Providencia, Klebsiella, Enterobacter, Serratia, and Acinetobacter (Mima-Herellea). Short-term treatment of serious infections caused by susceptible strains of microorganisms such as: septicemia (including neonatal sepsis); severe respiratory tract infections; CNS infections (meningitis); intra-abdominal infections (including peritonitis); complicated and recurrent urinary tract infections, where treatment is not possible with other less toxic antibiotics; Skin, bone, soft tissue, and joint infections; burn infections; postoperative infections (including post-vascular surgery).

Clarithromycin is useful for the treatment of: Upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis, otitis). Lower respiratory tract infections (bronchitis, pneumonia). Therapeutic indications for Clarithromycin: - Oral, in immediate-release and modified-release formulations: Adults and children ≥12 years: pharyngitis, tonsillitis, sinusitis (diagnosed), acute bronchitis, acute exacerbation of chronic bronchitis, bacterial pneumonia (community-acquired), mild-to-moderate skin and soft tissue infections, folliculitis, cellulitis, erysipelas. - Oral, in immediate-release formulations: Adults and children ≥12 years: localized or disseminated infection caused by M. avium or M. intracellulare, localized infection caused by M. chelonae, M. fortuitum, and M. kansaii. Gastric or duodenal ulcer associated with H. pylori (in conjunction with appropriate anti-ulcer medication). Prevention of disseminated M. avium complex infection in high-risk HIV patients (CD4 lymphocytes ≤ 50/mm³). Children > 12 months to 11 years: streptococcal pharyngitis, bacterial bronchitis and pneumonia, acute otitis media, impetigo, folliculitis, cellulitis, abscesses. - IV: Adults: parenteral treatment of streptococcal pharyngitis or tonsillitis if first-line treatment with beta-lactams is not possible or there is demonstrated susceptibility to S. pyogenes; diagnosed acute bacterial sinusitis; acute exacerbation of chronic bronchitis; mild-to-moderate skin and soft tissue infections if beta-lactams are not appropriate.